Carafate Suspension Generic Name & Formulations
Carafate Suspension Indications
Short-term (up to 8 weeks) treatment of active duodenal ulcer. Maintenance of healed duodenal ulcers (tabs only).
Carafate Suspension Dosage and Administration
Active: 1g 4 times daily on an empty stomach for 4–8 weeks. Maintenance: 1g 2 times daily.
Carafate Suspension Contraindications
Carafate Suspension Boxed Warnings
Carafate Suspension Warnings/Precautions
Susp: administer by oral route only; do not give intravenously. Monitor for glycemia in diabetic patients. Chronic renal failure. Dialysis. Tabs: swallowing impairment (eg, recent or prolonged intubation, tracheostomy, history of aspiration, dysphagia, others). Pregnancy (Cat.B). Nursing mothers.
Carafate Suspension Pharmacokinetics
Carafate Suspension Interactions
Avoid antacids within 30mins of dosing. May reduce absorption of tetracyclines, quinidine, levothyroxine, phenytoin, cimetidine, digoxin, ciprofloxacin, norfloxacin, ketoconazole, ranitidine, theophylline; dose concomitant drugs 2hrs before sucralfate. Additive aluminum load with aluminum-containing antacids. Monitor warfarin.
Carafate Suspension Adverse Reactions
Carafate Suspension Clinical Trials
Carafate Suspension Note
Carafate Suspension Patient Counseling